Holen Sie sich die Stockscreener-App
13.92
0.43%
0.06
Handel nachbörslich:
13.92
Jade Biosciences Inc Aktie (JBIO) Neueste Nachrichten
Jade Biosciences (NASDAQ:JBIO) Stock Price Expected to Rise, Guggenheim Analyst Says - Defense World
Jade Biosciences (NASDAQ:JBIO) Cut to Strong Sell at Zacks Research - Defense World
Zacks Research Downgrades Jade Biosciences (NASDAQ:JBIO) to Strong Sell - MarketBeat
Guggenheim Forecasts Strong Price Appreciation for Jade Biosciences (NASDAQ:JBIO) Stock - MarketBeat
Guggenheim raises Jade Biosciences stock price target on pipeline progress By Investing.com - Investing.com Canada
William Blair Upgrades Jade Biosciences (NASDAQ:JBIO) to Strong-Buy - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Jade Biosciences (NASDAQ:JBIO) Sees Unusually-High Trading Volume Following Analyst Upgrade - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Raised to "Strong-Buy" at William Blair - MarketBeat
TD Cowen reiterates Jade Biosciences stock rating on APRIL data By Investing.com - Investing.com Canada
William Blair initiates Jade Biosciences stock coverage with Outperform rating - Investing.com UK
Trading Recap: Is Jade Biosciences Inc a speculative investment2026 Breakouts & Accurate Buy Signal Alerts - baoquankhu1.vn
Wedbush Reaffirms Outperform Rating for Jade Biosciences (NASDAQ:JBIO) - MarketBeat
William Blair initiates Jade Biosciences stock coverage with Outperform rating By Investing.com - Investing.com South Africa
Signal Recap: Is Jade Biosciences Inc a speculative investment2026 Historical Comparison & Weekly Stock Performance Updates - baoquankhu1.vn
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Raised to “Strong-Buy” at Lifesci Capital - Defense World
Jade Biosciences (NASDAQ:JBIO) Upgraded by Lifesci Capital to "Strong-Buy" Rating - MarketBeat
Jade 10-K: $127.4M net loss, cash and investments $336.2M - TradingView
BTIG reiterates Buy on Jade Biosciences stock, $28 target maintained By Investing.com - Investing.com Canada
Stifel raises Jade Biosciences price target on IgAN market outlook - Investing.com
Jade Biosciences reports fourth quarter and full year 2025 financial results and provides corporate update - marketscreener.com
Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - The Manila Times
Jade Biosciences Stock Quote, Share Price, News and Analysis - Longbridge
Jade Biosciences Touts “Best-in-Class” Autoimmune Antibodies, JADE101 Phase 1 Readout Nears - Defense World
JBIO Should I Buy - Intellectia AI
JBIO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oppenheimer 36th Healthcare Life Sciences Conference: Spotlight On LGND, PHAR, CRBP, Among Others - RTTNews
Chipmakers Recap: Is Jade Biosciences Inc a stock for growth or value investors2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Can Jade Biosciences Inc. expand its profit marginsWeekly Profit Recap & Safe Entry Zone Tips - mfd.ru
Jade Biosciences (JBIO) grants RSUs and 247,500-share option to officer - Stock Titan
Weekly Earnings: Is Jade Biosciences Inc a speculative investmentJuly 2025 Spike Watch & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Jade Biosciences to Participate in Upcoming Conferences - Yahoo Finance
Jade Biosciences, Inc. (NASDAQ:JBIO) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Jade Biosciences (NASDAQ:JBIO) Shares Gap UpHere's Why - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Short Interest Update - MarketBeat
Aug Sentiment: Is Jade Biosciences Inc a speculative investment2025 Top Gainers & Long-Term Investment Growth Plans - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Up 8.1%What's Next? - MarketBeat
Wall Street Analysts Predict a 52.5% Upside in Jade Biosciences, Inc. (JBIO): Here's What You Should Know - MSN
Jade Biosciences (NASDAQ:JBIO) Stock Price Down 5.3%Here's What Happened - MarketBeat
Economics Weekly : There's Something About Kevin - William Blair
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock - MSN
H.C. Wainwright Initiates Jade Biosciences (JBIO) at Buy With $25 PT as JADE101 Eyes $926M Peak Revenue - Finviz
Short Interest in Jade Biosciences, Inc. (NASDAQ:JBIO) Increases By 47.9% - MarketBeat
Jade Biosciences, Inc. (NASDAQ:JBIO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Breakout Watch: What is AvePoint Incs TAM Total Addressable MarketMarket Trend Report & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
JBIO: Advancing novel autoimmune therapies with strong data, market potential, and rapid clinical timelines - TradingView
Valuation Update: What is the PEG ratio of Jade Biosciences IncJuly 2025 PostEarnings & AI Enhanced Trading Alerts - baoquankhu1.vn
Jade Biosciences (NASDAQ:JBIO) Trading Down 4.8%Should You Sell? - MarketBeat
Published on: 2026-01-10 20:20:04 - ulpravda.ru
How risky is Jade Biosciences Inc. stock nowPortfolio Profit Report & Fast Entry and Exit Trade Plans - Улправда
Will Jade Biosciences Inc. stock rally after Fed decisionsJuly 2025 Final Week & Real-Time Chart Pattern Alerts - Улправда
How Jade Biosciences Inc. stock reacts to global recession fearsFit and Size Notes & quick comparison of popular models - Улправда
Equities Analysts Offer Predictions for JBIO FY2025 Earnings - MarketBeat
How Jade Biosciences Inc. stock reacts to job market dataJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - Улправда
Economics Weekly : Another Possible Government Shutdown, Rising ACA Premiums, and Fiscal Cliffs Entering 2026 - William Blair
Jade Biosciences (NASDAQ:JBIO) Coverage Initiated at HC Wainwright - Defense World
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):